Nitroglycerin and Covera-hs drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Nitroglycerin (nitroglycerin) and Covera-hs (verapamil hydrochloride). Common drug interactions include hypotension among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people have when they take Nitroglycerin and Covera-hs. It is created by eHealthMe based on reports of 13 people who take the same drugs from the FDA, and is updated regularly.

What is Nitroglycerin?

Nitroglycerin has active ingredients of nitroglycerin. It is often used in chest pain. eHealthMe is studying from 52,884 Nitroglycerin users. Check the latest studies of Nitroglycerin.

What is Covera-hs?

Covera-hs has active ingredients of verapamil hydrochloride. eHealthMe is studying from 823 Covera-hs users. Check the latest studies of Covera-hs.

On Jul, 06, 2026

13 people who take Nitroglycerin and Covera-hs together, and have interactions are studied.

Nitroglycerin and Covera-hs drug interactions.

What are the common drug interactions of Nitroglycerin and Covera-Hs, by gender? *:

female:

Hypotension (abnormally low blood pressure)
Cardiac tamponade (fluid accumulates in heart covering)
Thromboembolism (obstruction of artery by blood clot)
Acidosis (build-up of carbon dioxide in the blood)
Acute circulatory failure (shock)
Encephalopathy (functioning of the brain is affected by some agent or condition)
Haemoglobin decreased
Haemorrhage (bleeding)
Multi-organ failure (multisystem organ failure)
Ventricular fibrillation (abnormally irregular heart rhythm)

male:

Chronic kidney disease
Renal failure (kidney dysfunction)
Cardioactive drug level above therapeutic
Cardioactive drug level below therapeutic
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)
Emotional distress
Heart rate irregular
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)

What are the common drug interactions of Nitroglycerin and Covera-Hs, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Blood pressure increased
Blood urea increased
Brain natriuretic peptide increased
Cardiac failure congestive
Cardioactive drug level above therapeutic
Cardioactive drug level below therapeutic
Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
Dyspnoea (difficult or laboured respiration)
Emotional distress

50-59:

Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
Chronic kidney disease
Hepatic cirrhosis (chronic liver disease characterized by replacement of liver tissue by fibrosis, scar tissue)
Hepatic encephalopathy (spectrum of neuropsychiatric abnormalities in patients with liver failure)
Hepatic failure (liver failure)
Hepatic neoplasm malignant (liver cancer)
Liver fatty (fat deposition of liver)
Metastases to large intestine (cancer spreads to large intestine)
Peritonitis (inflammation of the peritoneum, the thin tissue that lines the inner wall of the abdomen and covers most of the abdominal organs)
Renal failure (kidney dysfunction)

60+:

Cardiac tamponade (fluid accumulates in heart covering)
Hypotension (abnormally low blood pressure)
Anaemia (lack of blood)
Arterial rupture
Atrioventricular block (heart block)
Atrioventricular block complete (heart block complete)
Blood pressure increased
Cardiac disorder
Cardiac failure
Cardiac fibrillation (uncontrolled muscle contraction of heart)

What are the existing conditions these people have? *

High Blood Pressure: 4 people, 30.77%
Fluid Retention (an abnormal accumulation of fluid in the blood): 4 people, 30.77%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 30.77%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 3 people, 23.08%
Diabetes: 3 people, 23.08%
Pain: 3 people, 23.08%
Oedema (fluid collection in tissue): 3 people, 23.08%
Muscle Spasms (muscle contraction): 3 people, 23.08%
High Blood Cholesterol: 3 people, 23.08%
Inflammation: 3 people, 23.08%

* Approximation only. Some reports may have incomplete information.

Do you take Nitroglycerin and Covera-hs?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously